학술논문
Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study
Document Type
Article
Author
Llanos-Cuentas, Alejandro; Casapia, Martin; Chuquiyauri, Raúl; Hinojosa, Juan-Carlos; Kerr, Nicola; Rosario, Maria; Toovey, Stephen; Arch, Robert H; Phillips, Margaret A; Rozenberg, Felix D; Bath, Jade; Ng, Caroline L; Cowell, Annie N; Winzeler, Elizabeth A; Fidock, David A; Baker, Mark; Möhrle, Jörg J; Hooft van Huijsduijnen, Rob; Gobeau, Nathalie; Araeipour, Nada; Andenmatten, Nicole; Rückle, Thomas; Duparc, Stephan
Source
In The Lancet Infectious Diseases August 2018 18(8):874-883
Subject
Language
ISSN
1473-3099